Based on latest results, NVL has underlying EBITDA of $12-$13M with 66 vets with enterprise value of $156M, taking the midpoint means it is trading today at EV/EBITDA of 12.5. Using the same valuation ratio, and considering only the Australian vets business of GXL which has underlying EBITDA of $24.6M, the Aust vet business should attract a valuation of $307.5M.
Today's closing price of $3.97 implies Greencross Enterprise Value of $744M. This means the rest of the retail business in Australia and the vets + retail in NZ is valued at (744-307)/73 = EV/EBITDA ratio of 5.98 (let's call it 6).
In comparison with major retail, e.g. Woolies, EBITDA = $3651M, EV of $39844M, giving a 10.9 EV/EBITDA ratio. Or compare it with JBH, EBITDA = $411.7, EV = $3408M, giving EV/EBITDA ratio of 8.28. If we just use 9 as the average EV/EBITDA ratio for the rest of the business of GXL, that will give us 9 x 73 = $657M. Add that to the Aust Vet Business, GXL should trade at $307+$657 = $964M!
That means that GXL target price should be $8.03, and at today's price, it needs to go up by at least 100% from today! Note that this does not take into account the revenue increase that occurs in FY19, which will only make the price go higher..
- Forums
- ASX - By Stock
- GXL
- GXL Target Price of $8.03/share
GXL Target Price of $8.03/share
-
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online